Miriam Kidron
Company: Oramed
Job title: Chief Scientific Officer
Seminars:
Workshop F: Exploring Non-Invasive Tests & Biomarkers for MASH 2:30 pm
This workshop will focus on the potential of oral insulin as a novel treatment for MASH. A recent Phase 2, double-blind study conducted across five sites demonstrated the advantages of oral insulin over placebo in improving liver function and reducing disease progression. Attendees will gain insights into the therapeutic potential of oral insulin and its…Read more
day: Clinical Track Workshop F